American Century Companies’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,361
Closed -$423K 2914
2025
Q4
$423K Buy
53,361
+81
+0.2% +$517 ﹤0.01% 2555
2025
Q3
$183K Hold
53,280
﹤0.01% 2707
2025
Q2
$220K Buy
53,280
+998
+2% +$3.33K ﹤0.01% 2724
2025
Q1
$125K Buy
52,282
+718
+1% +$2.02K ﹤0.01% 2814
2024
Q4
$188K Buy
51,564
+4,964
+11% +$22.6K ﹤0.01% 2789
2024
Q3
$294K Buy
46,600
+10,652
+30% +$71.7K ﹤0.01% 2653
2024
Q2
$240K Buy
35,948
+8,527
+31% +$50.4K ﹤0.01% 2692
2024
Q1
$145K Buy
27,421
+2,487
+10% +$11.7K ﹤0.01% 2815
2023
Q4
$129K Buy
24,934
+9,026
+57% +$27.9K ﹤0.01% 2779
2023
Q3
$53.6K Buy
15,908
+5,370
+51% +$35.3K ﹤0.01% 2800
2023
Q2
$87.3K Buy
+10,538
New +$94.9K ﹤0.01% 2703

Other funds holding SGHT

American Century Companies's SGHT Position: Q1 2026 in Review

American Century Companies sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 53,361 shares — an estimated $423K sold.

American Century Companies first reported a position in SGHT in Q2 2023 and held it in 11 quarters. The position peaked at $423K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • American Century Companies reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
  • American Century Companies sold 53,361 Sight Sciences shares in Q1 2026, an estimated $423K.
  • American Century Companies first reported a position in Sight Sciences in Q2 2023 and held it in 11 quarters.
  • American Century Companies's Sight Sciences position peaked at $423K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.